Cargando…

Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice

Pungent spice constituents such as piperine, capsaicin and [6]-gingerol consumed via daily diet or traditional Chinese medicine, have been reported to possess various pharmacological activities. These dietary phytochemicals have also been reported to inhibit P-glycoprotein (P-gp) in vitro and act as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hwan, Shin, Soyoung, Yoo, Sun Dong, Shin, Beom Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017107/ https://www.ncbi.nlm.nih.gov/pubmed/29414892 http://dx.doi.org/10.3390/molecules23020349

Ejemplares similares

Liquid Chromatography-Tandem Mass Spectrometry of Desoxo-Narchinol a and Its Pharmacokinetics and Oral Bioavailability in Rats and Mice
por: Thapa, Subindra Kazi, et al.
Publicado: (2019)

Determination of pharmacokinetics and tissue distribution of a novel lutetium-labeled PSMA-targeted ligand, (177)Lu-DOTA-PSMA-GUL, in rats by using LC–MS/MS
por: Song, Chang Ho, et al.
Publicado: (2022)

Toxicokinetics, Percutaneous Absorption and Tissue Distribution of Benzophenone-3, an UV Filtering Agent, in Rats
por: Jung, Woohyung, et al.
Publicado: (2022)

Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis
por: Oh, Hyeon Seok, et al.
Publicado: (2022)

Effect of Sipjeondaebo-Tang on the Pharmacokinetics of S-1, an Anticancer Agent, in Rats Evaluated by Population Pharmacokinetic Modeling
por: Kim, Tae Hwan, et al.
Publicado: (2017)

Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
por: Asperen, J van, et al.
Publicado: (1999)

The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
por: Patel, Krupa J, et al.
Publicado: (2009)

Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats
por: Pang, Minyeong, et al.
Publicado: (2022)

Plasma Pharmacokinetics and Tissue Distribution of Doxorubicin in Rats following Treatment with Astragali Radix
por: Huang, Yin, et al.
Publicado: (2022)

Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs
por: Shin, Soyoung, et al.
Publicado: (2019)

The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluid
por: Karbownik, Agnieszka, et al.
Publicado: (2019)

Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
por: Schuurhuis, G. J., et al.
Publicado: (1991)

Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
por: Cho, Hyun-Jong, et al.
Publicado: (2015)

Establishment of Level a In Vitro–In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study
por: Lee, Da Young, et al.
Publicado: (2022)

Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia
por: Dicheva, Bilyana M., et al.
Publicado: (2015)

Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine
por: Kim, Tae Hwan, et al.
Publicado: (2017)

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
por: Fenneteau, Frédérique, et al.
Publicado: (2009)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression
por: Carabias, Pablo, et al.
Publicado: (2022)

Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice
por: Fasinu, Pius S., et al.
Publicado: (2022)

Physiologically Relevant In Vitro-In Vivo Correlation (IVIVC) Approach for Sildenafil with Site-Dependent Dissolution
por: Kim, Tae Hwan, et al.
Publicado: (2019)

Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas
por: Villar, Victor Hugo, et al.
Publicado: (2012)

Distribution of 4'epi-doxorubicin in human tissues.
por: Italia, C., et al.
Publicado: (1983)

Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats
por: Kim, Tae Hwan, et al.
Publicado: (2018)

Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles
por: Baek, Miri, et al.
Publicado: (2012)

Pharmacokinetic Alteration of Baclofen by Multiple Oral Administration of Herbal Medicines in Rats
por: Kim, Tae Hwan, et al.
Publicado: (2014)

Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice.
por: Webster, L. K., et al.
Publicado: (1996)

Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice
por: Wu, Yi Shuan, et al.
Publicado: (2021)

Pharmacokinetics and Tissue Distribution of (13)C-Labeled Succinic Acid in Mice
por: Jung, Yonghwan, et al.
Publicado: (2022)

In Silico and In Vitro Identification of P-Glycoprotein Inhibitors from a Library of 375 Phytochemicals
por: Schäfer, Julia, et al.
Publicado: (2023)

Enhanced Cellular Uptake and Pharmacokinetic Characteristics of Doxorubicin-Valine Amide Prodrug
por: Park, Yohan, et al.
Publicado: (2016)

Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function
por: Muzzammil, T, et al.
Publicado: (2001)

The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
por: Gao, Wei, et al.
Publicado: (2014)

Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin
por: Szwed, Marzena, et al.
Publicado: (2014)

Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats
por: Gao, Yan, et al.
Publicado: (2016)

Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.
por: Galettis, P., et al.
Publicado: (1994)

Benzisothiazolinone: Pharmacokinetics, Tissue Distribution, and Mass Balance Studies in Rats
por: Jo, Seong Jun, et al.
Publicado: (2023)

Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein
por: Wang, Shengpeng, et al.
Publicado: (2014)

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.
por: Colombo, T., et al.
Publicado: (1996)

Absorption, Metabolic Stability, and Pharmacokinetics of Ginger Phytochemicals
por: Mukkavilli, Rao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b63qu8s1bdu0gftjqvg30irml9